Significant Milestone: Biomerica secures IVDR (In Vitro Diagnostic Regulation) certification, ensuring compliance with stringent European Union standards and allowing sales of the products in the ...
IRVINE, Calif. - Biomerica, Inc. (NASDAQ:BMRA), a developer of medical diagnostic solutions, has achieved a significant regulatory milestone with the CE marking of its food intolerance products ...
Biomerica (BMRA) announces that its food intolerance products for Crohn’s Disease and Ulcerative Colitis have achieved CE-marking under the European Union’s new In Vitro Diagnostic Medical ...
Significant Milestone: Biomerica secures IVDR (In Vitro Diagnostic Regulation) certification, ensuring compliance with stringent European Union standards and allowing sales of the products in the EU ...
IRVINE, Calif. - Biomerica, Inc. (NASDAQ:BMRA), a developer of medical diagnostic solutions, has achieved a significant regulatory milestone with the CE marking of its food intolerance products for ...
Biomerica, Inc. has achieved IVDR certification for its food intolerance products designed for managing Crohn's Disease and Ulcerative Colitis, marking a significant step in compliance with ...
Significant Milestone: Biomerica secures IVDR (In Vitro Diagnostic Regulation) certification, ensuring compliance with stringent European Union standards and allowing sales of the products in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback